LYT-100 in Post-acute COVID-19 Respiratory Disease
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Covid19, Post-acute COVID-19 Respiratory Disease
In brief
This study is being conducted in two parts, A and B. Part A is a randomized, double-blind, parallel arm study to evaluate the safety and efficacy of LYT-100 compared to placebo in adults with post-acute COVID-19 respiratory complications. Part B is an Open Label Extension (OLE) study for patients who complete Part A.
Key facts
- Study ID
- NCT04652518
- Run by
- PureTech
- People needed
- 185
- Starts
- 2020-12-11
- Expected to finish
- 2022-07-18
- Last updated by the study team
- 2026-06-23
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- North Alabama Medical Center — Florence, Alabama, United States
- University of Southern California - Keck School of Medicine — Los Angeles, California, United States
- Vista Health Research — Miami, Florida, United States
- Central Florida Pulmonary Group — Orlando, Florida, United States
- Coastal Pulmonary and Critical Care — St. Petersburg, Florida, United States
- Tampa General Hospital — Tampa, Florida, United States
- Center for Advanced Research and Education — Gainesville, Georgia, United States
- GenHarp Clinical Solutions — Evergreen Park, Illinois, United States
- Circuit Clinical/Crystal Run Healthcare LLP — Middletown, New York, United States
- Southeastern Research Center — Winston-Salem, North Carolina, United States
- University of Pittsburg Medical Center — Pittsburgh, Pennsylvania, United States
- Affinity Health Corp — Nashville, Tennessee, United States
- Frostwood Family Medicine — Houston, Texas, United States
- The University of Texas Health Sciences Center at San Antonio — San Antonio, Texas, United States
- Clinica Central S.A — Villa Regina, Río Negro Province, Argentina
- Fundacion Estudios Clinicos — Rosario, Santa Fe Province, Argentina
- Investigaciones en Patologias Respiratorias — San Miguel de Tucumán, Tucumán Province, Argentina
- CETI - Centro de Estudos em Terapias Inovadoras — Curitiba, Paraná, Brazil
- Hospital de Clinicas de Porto Alegre — Porto Alegre, Rio Grande do Sul, Brazil
- Instituto de Doencas do Torax — Rio de Janeiro, Brazil
- PMSI Republican Clinical Hospital "T. Mosneaga" — Chisinau, Moldova
- University of the Philippines Manila - Philippine General Hospital (PGH) — Manila, Philippines
- Quirino Memorial Medical Center (QMMC) — Quezon City, Philippines
- National Institute for Infectious Diseases "Prof. Dr. Matei Balş" (Arensia Eploratory Medicine) — Bucharest, Romania
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.